NEURODEGENERATIVE DISEASES: ALZHEIMERS AND PARKINSONS DISEASES An analysis of the mechanisms of action of GLP-1 and GLP-1RAs indicates that these compounds, by activating GLP-1R, modulate the molecular and cellular changes, and influence the shared processes that determine the phenomenology of neurodegenerative diseases (NDD) and a number of other brain diseases [36]
The process begins with Vitamin B12 in the injection, which plays a pivotal role in producing energy as well as the metabolism of proteins and fats
Transl Stroke Res , 11 , 910923
For example, some programs have demonstrated that members who dont take GLP-1s but do engage in intensive lifestyle modification still achieve significant weight loss (around 9% loss after one year, according to data from one of our partners)
Its estimated that 12% of Americans have used a GLP-1 agonist
El GLP-1 ayuda al cuerpo a controlar el hambre